FRANKLIN LAKES, N.J., July 25, 2023 /PRNewswire/ The Board of Directors of BD has declared a quarterly dividend of $0.91 per common share, payable on September 29, 2023 to holders of record on.
FRANKLIN LAKES, N.J., July 24, 2023 /PRNewswire/ BD Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration 510 clearance for the.
/PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Dr. Joanne.
FRANKLIN LAKES, N.J., July 24, 2023 /PRNewswire/ BD , a leading global medical technology company, today announced the appointment of Dr. Joanne Waldstreicher to its board of directors. .
BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps,.